A new Plantation Close EC in Tengah ~ Jointly developed by the renowned Hoi Hup Realty and Sunway Developments in a tranquil living environment dubbed as Singapore’s first ‘Forest Town’. Numerous ...

Novo Nordisk has asked the Food and Drug Administration to bar compounding pharmacies from making copies of its blockbuster weight loss drug semaglutide, arguing that the medication is too complex ...

The Danish drug company Novo Nordisk has been sanctioned by the UK pharmaceutical industry regulator over the way it has promoted its weight loss medications semaglutide (Ozempic/Wegovy) and ...

Assistir Pedro Almodóvar é sempre uma experiência surpreendente, já que nunca se sabe quais sensações o diretor irá trazer na tela. Renomado e com títulos como “Volver” e “A Pele que Habito”, o ...

Patients taking Novo Nordisk A/S’s Ozempic were at significantly reduced risk of being diagnosed with Alzheimer’s, according to new research that adds to the evidence surrounding the drug’s ...

Conforme contamos no Jornal do Carro, a Renault prepara um SUV médio inédito no Brasil para 2025. O novo modelo vai estrear a tecnologia híbrida flex da montadora francesa no País. Ele não será o ...

Oct 23 (Reuters) - Novo Nordisk (NOVOb.CO), opens new tab on Tuesday asked the U.S. Food and Drug Administration to ban compounding pharmacies from making copycat versions of its popular weight ...

The group of like-named companies that include Novo Holdings and Novo Nordisk—the two tied to a multibillion-dollar buyout of Catalent currently under FTC review—ultimately send proceeds to the Novo ...

Novo Nordisk wants the Food and Drug Administration (FDA) to prevent compounding pharmacies from manufacturing their own versions of the company’s popular weight loss drug Wegovy and diabetes ...

Denmark unveiled an Nvidia-powered supercomputer that will be used by researchers from Novo Nordisk A/S and other Danish pharmaceutical companies as they seek novel drugs and smarter trial designs ...

Novo has fired the most recent shot, asking the U.S. regulator to prevent compounders from manufacturing copycat versions of its juggernaut diabetes and obesity treatments Ozempic and Wegovy ...

Novo Nordisk asked the Food and Drug Administration to prevent compounding pharmacies from making cheaper versions of its popular weight loss injection Wegovy and diabetes treatment Ozempic.